Phosphoproteome analysis reveals differences in phosphosite profiles between tumorigenic and non-tumorigenic epithelial cells

Journal of Proteomics

Volumn 96, Issue , 2014, Pages 67-81

  Winck, Flavia V ^a   Belloni, Marília ^a   Pauletti, Bianca A ^a   Zanella, Jackeline de Lima ^a   Domingues, Romênia R ^a   Sherman, Nicholas E ^b   Paes Leme, Adriana F ^a  

^a BRAZILIAN CENTER FOR RESEARCH IN ENERGY AND MATERIALS CNPEM   (Brazil)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Human; Networks; Oral cancer; Phosphoproteome; Proteomics; Signaling pathways

Indexed keywords

ALPHA CATENIN; ARGININE; BETA4 INTEGRIN; CELL CYCLE PROTEIN; FORKHEAD TRANSCRIPTION FACTOR; MATRIX PROTEIN; PHOSPHOPEPTIDE; PHOSPHOPROTEIN; POLYPEPTIDE; PROTEIN ZO2; PROTEOME; SERINE; UBIQUITIN CONJUGATING ENZYME E2;

ACETYLATION; ARTICLE; CARCINOGENESIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA METHYLATION; DNA REPLICATION; ENDOCYTOSIS; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; ION EXCHANGE CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MOLECULAR DYNAMICS; MOUTH SQUAMOUS CELL CARCINOMA; NUCLEIC ACID METABOLISM; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEOMICS; REGULATORY MECHANISM; SERTOLI CELL; SIGNAL TRANSDUCTION; TIGHT JUNCTION;

HUMAN; NETWORKS; ORAL CANCER; PHOSPHOPROTEOME; PROTEOMICS; SIGNALING PATHWAYS;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; EPITHELIAL CELLS; HUMANS; MOUTH NEOPLASMS; NEOPLASM PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEOME;

EID: 84888123329     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.10.039     Document Type: Article

References (32)

1. van der Waal I. Are we able to reduce the mortality and morbidity of oral cancer; some considerations. Med Oral Patol Oral Cir Bucal 2013, 18:e33-e37.
2. Cairns R.A., Harris I.S., Mak T.W. Regulation of cancer cell metabolism. Nat Rev Cancer 2011, 11:85-95.
3. Harsha H.C., Pandey A. Phosphoproteomics in cancer. Mol Oncol 2010, 4:482-495.
4. Kolch W., Pitt A. Functional proteomics to dissect tyrosine kinase signalling pathways in cancer. Nat Rev Cancer 2010, 10:618-629.
5. Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J., et al. Toward a comprehensive characterization of a human cancer cell phosphoproteome. J Proteome Res 2013, 12:260-271.
6. Zanivan S., Meves A., Behrendt K., Schoof E.M., Neilson L.J., Cox J., et al. In vivo SILAC-based proteomics reveals phosphoproteome changes during mouse skin carcinogenesis. Cell Rep 2013, 3:552-566.
7. Rheinwald J.G., Beckett M.A. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res 1981, 41:1657-1663.
8. Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988, 106:761-771.
9. Aragao A.Z., Belloni M., Simabuco F.M., Zanetti M.R., Yokoo S., Domingues R.R., et al. Novel processed form of syndecan-1 shed from SCC-9 cells plays a role in cell migration. PLoS One 2012, 7:e43521.
10. Breitkreutz D., Schoop V.M., Mirancea N., Baur M., Stark H.J., Fusenig N.E. Epidermal differentiation and basement membrane formation by HaCaT cells in surface transplants. Eur J Cell Biol 1998, 75:273-286.
11. Rheinwald J.G., Beckett M.A. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. Cancer Res 1981, 41:1657-1663.
12. Villen J., Gygi S.P. The SCX/IMAC enrichment approach for global phosphorylation analysis by mass spectrometry. Nat Protoc 2008, 3:1630-1638.
13. Cox J., Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 2008, 26:1367-1372.
14. Maere S., Heymans K., Kuiper M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 2005, 21:3448-3449.
15. Cline M.S., Smoot M., Cerami E., Kuchinsky A., Landys N., Workman C., et al. Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2007, 2:2366-2382.
16. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 1995, 57:289-300.
17. Mostafavi S., Ray D., Warde-Farley D., Grouios C., Morris Q. GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function. Genome Biol 2008, 9(Suppl. 1):S4.
18. Hornbeck P.V., Kornhauser J.M., Tkachev S., Zhang B., Skrzypek E., Murray B., et al. PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res 2012, 40:D261-D270.
19. Chou M.F., Schwartz D. Biological sequence motif discovery using motif-x. Curr Protoc Bioinformatics 2011, 5-24. Chapter 13:Unit 13.
20. Schwartz D., Gygi S.P. An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets. Nat Biotechnol 2005, 23:1391-1398.
21. Carrillo B., Yanofsky C., Laboissiere S., Nadon R., Kearney R.E. Methods for combining peptide intensities to estimate relative protein abundance. Bioinformatics 2010, 26:98-103.
22. Shannon P., Markiel A., Ozier O., Baliga N.S., Wang J.T., Ramage D., et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003, 13:2498-2504.
23. Waugh M.G. Phosphatidylinositol 4-kinases, phosphatidylinositol 4-phosphate and cancer. Cancer Lett 2012, 325:125-131.
24. Lever E., Sheer D. The role of nuclear organization in cancer. J Pathol 2010, 220:114-125.
25. Zhang S., Tang Q., Xu F., Xue Y., Zhen Z., Deng Y., et al. RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors. Mol Cancer Res 2009, 7:570-580.
26. Xu Y., Xu C., Price B.D. Mechanistic links between ATM and histone methylation codes during DNA repair. Prog Mol Biol Transl Sci 2012, 110:263-288.
27. Heessen S., Fornerod M. The inner nuclear envelope as a transcription factor resting place. EMBO Rep 2007, 8:914-919.
28. Goldman R.D., Gruenbaum Y., Moir R.D., Shumaker D.K., Spann T.P. Nuclear lamins: building blocks of nuclear architecture. Genes Dev 2002, 16:533-547.
29. Butin-Israeli V., Adam S.A., Goldman A.E., Goldman R.D. Nuclear lamin functions and disease. Trends Genet 2012, 28:464-471.
30. Blencowe B.J., Bauren G., Eldridge A.G., Issner R., Nickerson J.A., Rosonina E., et al. The SRm160/300 splicing coactivator subunits. RNA 2000, 6:111-120.
31. Irimia M., Blencowe B.J. Alternative splicing: decoding an expansive regulatory layer. Curr Opin Cell Biol 2012, 24:323-332.
32. Wu Y., Wang X., Wu F., Huang R., Xue F., Liang G., et al. Transcriptome profiling of the cancer, adjacent non-tumor and distant normal tissues from a colorectal cancer patient by deep sequencing. PLoS One 2012, 7:e41001.